AMSTERDAM (Reuters) – Dutch specialty chemicals maker DSM on Tuesday beat analyst expectations with a 13% jump in fourth-quarter core profit to 440 million euros ($497.95 million), as demand for its nutritional products remained strong despite higher prices.

Analysts in a company-compiled poll on average had predicted adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) would rise to 424 million euros, from 390 million a year before.

($1 = 0.8836 euros)

(Reporting by Bart Meijer; Editing by Himani Sarkar)